Pharmarise Holdings Corporation, June-August (1Q) Net Income Turns to Loss

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Wed Sep 25, 2024 5:00 pm JST Earnings

2796 Pharmarise Holdings Corporation 【J-GAAP】

Earnings Report

Pharmarise Holdings Corporation <2796> [TSE-S] announced its financial results after the market closed on September 25th (17:00). The consolidated net income/loss for the first quarter of the fiscal year ending May 2025 (June to August) turned into a loss of 131 million yen (compared to a profit of 123 million yen in the same period last year).

In the most recent three-month period, from June to August (1Q), the operating profit margin worsened from 2.5% in the same period last year to 0.3%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jun - Aug, 2022	12,861	348	341	111	11.9	60.2	Oct 13, 2022	J-GAAP
Jun - Aug, 2023	13,471	331	331	123	13.1	47.2	Oct 2, 2023	J-GAAP
Jun - Aug, 2024	15,231	52	23	-131	-11.7	5.4	Sep 25, 2024	J-GAAP
YoY	+13.1%	-84.3%	-93.1%	－	－

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jun - Nov, 2023	26,948	710	701	273	28.3	0	Dec 25, 2023	J-GAAP
Jun - Nov, 2024 Guidance	30,539	483	428	31	2.7	0	Jun 28, 2024	J-GAAP
YoY	+13.3%	-32.0%	-38.9%	-88.6%	-90.3%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
May, 2023	52,030	1,438	1,431	333	35.5	14	Jul 11, 2023	J-GAAP
May, 2024	54,466	916	833	-351	-33.4	20	Jun 28, 2024	J-GAAP
May, 2025 Guidance	60,880	949	804	40	3.5	14	Jun 28, 2024	J-GAAP
YoY	+11.8%	+3.6%	-3.5%	－	－

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jun - Aug, 2023	13,471	331	331	123	13.1	2.5	Oct 2, 2023	J-GAAP
Sep - Nov, 2023	13,477	379	370	150	15.5	2.8	Dec 25, 2023	J-GAAP
Dec - Feb, 2023	13,726	153	98	-96	-9.3	1.1	Mar 25, 2024	J-GAAP
Mar - May, 2024	13,792	53	34	-528	-50.3	0.4	Jun 28, 2024	J-GAAP
Jun - Aug, 2024	15,231	52	23	-131	-11.7	0.3	Sep 25, 2024	J-GAAP
YoY	+13.1%	-84.3%	-93.1%	－	－